Mesa Laboratories (MLAB) Gains from Investment Securities (2011 - 2025)

Mesa Laboratories has disclosed Gains from Investment Securities across 15 years of filings, most recently posting -$1.2 million for Q2 2025.

• Gains from Investment Securities for Q2 2025 came in at -$1.2 million, down 20280.82% year-over-year; the trailing twelve-month figure through Jun 2025 was $3.6 million (up 58553.54% YoY), and the FY2025 annual result was $17000.0, down 91.24% from the prior year.
• Gains from Investment Securities came in at -$1.2 million for Q2 2025 at Mesa Laboratories, down from $3.9 million in the prior quarter.
• In the past five years, Gains from Investment Securities ranged from a high of $8.3 million in Q1 2021 to a low of -$2.0 million in Q1 2023.
• The 5-year median for Gains from Investment Securities is $3051.0 (2022), against an average of $720336.8.
• Across the five-year window, Gains from Investment Securities surged 58344.44% in 2023 and tumbled 20280.82% in 2025, its largest moves.
• Mesa Laboratories' Gains from Investment Securities stood at $253000.0 in 2021, then sank by 99.31% to $1757.0 in 2022, then tumbled by 94.42% to $98.0 in 2023, then plunged by 67.35% to $32.0 in 2024, then tumbled by 3906350.0% to -$1.2 million in 2025.
• The last three Gains from Investment Securities figures came in at -$1.2 million (Q2 2025), $3.9 million (Q1 2025), and $32.0 (Q4 2024), per Business Quant data.